The DOI matches its Crossref record; 139 of the 140 references it cites were found in a registry or an index.
Network medicine: a network-based approach to human disease
Open accessAbstract
Given the functional interdependencies between the molecular components in a human cell, a disease is rarely a consequence of an abnormality in a single gene, but reflects the perturbations of the complex intracellular and intercellular network that links tissue and organ systems. The emerging tools of network medicine offer a platform to explore systematically not only the molecular complexity of a particular disease, leading to the identification of disease modules and pathways, but also the molecular relationships among apparently distinct (patho)phenotypes. Advances in this direction are essential for identifying new disease genes, for uncovering the biological significance of disease-associated mutations identified by genome-wide association studies and full-genome sequencing, and for identifying drug targets and biomarkers for complex diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Few genes act in isolation but rather affect the function of other genes to influence a particular phenotype via in cellular networks or pathways (Barabasi et al., 2011; Geschwind and Konopka, 2009).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Barabasi et al., 2011
In the citing paper
“Communities of co-expressed proteins can be linked to disease processes, and the most strongly correlated proteins, or “hubs,” within these co-expression modules are enriched in key drivers of disease pathogenesis5–10.”
In the citing paper
“Machine learning has been used to analyze high-throughput molecular interactomes to unravel genetic architecture perturbed in disease12,13 and help design therapies to target them14.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [14]
In the citing paper
“This evaluation method aligns with the approach predominantly used in the literature12,14–16,18–20.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [14]
In the citing paper
“TxGNN leverages an additional metric learning component for zero-shot prediction, capitalizing on the insight that diseases can share disease-associated genetic and genomic networks10,14 and, thus, medical knowledge of disease-associated networks can be transferred by the model from well-annotated diseases to other diseases to enhance predictions on diseases with limited treatment options (Fig. 2a”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [14]
In the citing paper
“In protein interaction networks, for instance, mutations in interacting proteins often lead to similar diseases [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Further, essential genes are often found in hubs of a molecular network whereas non-essential genes (e.g., those associated with disease) are located on the periphery [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Given by the shared components and disease module hypotheses [13], cellular components associated with the same phenotype tend to cluster in the same network neighborhood [16].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Thus, the network parsimony principle dictates that shortest molecular paths between known disease-associated components tend to correlate with causal molecular pathways [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“First, interacting entities are typically more similar than non-interacting entities, as implicated by the local hypothesis [13].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“The organizing principles governing networks link network structure to molecular phenotypes, biological roles, disease, and health, thus providing the conceptual grounding that, we argue, can explain the successes (and limitations) of graph representation learning and inform future development of the field.”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Because such processes are costly and time-consuming, in silico approaches have been adopted into the drug discovery pipeline.”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
In the citing paper
“Modern drug discovery requires elucidating a candidate drug’s chemical structure, identifying its drug targets, quantifying its efficacy and toxicity, and detecting its potential side effects [13, 14, 32, 164].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collective dynamics of ‘small-world’ networks
Watts, D. J., & Strogatz, S. H. (1998) · Nature · doi:10.1038/30918 · Cited by 43,060
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
Self-citationStatistical mechanics of complex networks
Albert, R., & Barabási, A.-L. (2002) · Reviews of Modern Physics · doi:10.1103/revmodphys.74.47 · Cited by 20,471
Self-citationCommunity structure in social and biological networks
Girvan, M., & Newman, M. E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122653799 · Cited by 15,502
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Self-citationNetwork motifs: simple building blocks of complex networks.
Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., & Alon, U. (2002) · Science · doi:10.1126/science.298.5594.824 · Cited by 7,368
Uncovering the overlapping community structure of complex networks in nature and society
Palla, G., Derényi, I., Farkas, I., & Vicsek, T. (2005) · Nature · doi:10.1038/nature03607 · Cited by 5,373
Lethality and centrality in protein networks
Jeong, H., Mason, S., Barabási, A., & Oltvai, Z. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,327
Self-citationThe Large-Scale Organization of Metabolic Networks
Jeong, H., Tombor, B., Albert, R., Oltvai, Z. N., & Barabási, A.-L. (2000) · Nature · doi:10.1038/35036627 · Cited by 4,972
Self-citation
Flagged first, then by citations
1 of the 140 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,013
Li, X., Xiang, J., Wang, J., Li, J., Wu, F., & Li, M. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.2973148 · Cited by 123
Chen, J., Wang, Y., Gao, Y., Hu, L.-S., Yang, J.-W., Wang, J., Sun, W., Liang, Z., Cao, Y., & Cao, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110281 · Cited by 120
In vivo characterization of the early states of the amyloid-beta network
Sepulcre, J., Sabuncu, M. R., Becker, A., Sperling, R., & Johnson, K. A. (2013) · Brain · doi:10.1093/brain/awt146 · Cited by 117
Genomics and anterior segment dysgenesis: a review
Itō, Y., & Walter, M. A. (2013) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12152 · Cited by 119
Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders
Tabarés‐Seisdedos, R., & Rubenstein, J. L. R. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3464 · Cited by 118
Siggaard, T., Reguant, R., Jørgensen, I. F., Haue, A. D., Lademann, M., Aguayo‐Orozco, A., Hjaltelin, J. X., Jensen, A. B., Banasik, K., & Brunak, S. (2020) · Nature Communications · doi:10.1038/s41467-020-18682-4 · Cited by 121
A generalized gravity model for influential spreaders identification in complex networks
Li, H., Shang, Q., & Deng, Y. (2020) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2020.110456 · Cited by 118
Wang, R., Maron, B. A., & Loscalzo, J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318731 · Cited by 125
Self-citationPredicting Parkinson's Disease Genes Based on Node2vec and Autoencoder
Peng, J., Guan, J., & Shang, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00226 · Cited by 114
Using biological networks to integrate, visualize and analyze genomics data
Charitou, T., Bryan, K. R., & Lynn, D. J. (2016) · Genetics Selection Evolution · doi:10.1186/s12711-016-0205-1 · Cited by 121
Identifying influential nodes in complex networks: A node information dimension approach
Bian, T., & Deng, Y. (2018) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/1.5030894 · Cited by 115
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Li, Y.-B., Fu, Q., Guo, M., Du, Y., Chen, Y., & Cheng, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03075-8 · Cited by 134
Pavlopoulos, G. A., Malliarakis, D., Papanikolaou, N., Θεοδοσίου, Θ., Enright, A. J., & Iliopoulos, I. (2015) · GigaScience · doi:10.1186/s13742-015-0077-2 · Cited by 118
Jia, P., & Zhao, Z. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003460 · Cited by 114
Allergen Immunotherapy (AIT): a prototype of Precision Medicine
Canonica, G. W., Bachert, C., Hellings, P. W., Ryan, D. P., Valovirta, E. J., Wickman, M. C., Beaumont, O. D., & Bousquet, J. J. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0079-7 · Cited by 115
Prediction of protein assemblies, the next frontier: The CASP14‐CAPRI experiment
Lensink, M. F., Brysbaert, G., Mauri, T., Nadzirin, N., Velankar, S. S., Chaleil, R. A. G., Clarence, T., Bates, P. A., Kong, R., Liu, B., et al. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26222 · Cited by 106
You, S., Yoo, S., Choi, S., Kim, J., Park, S.-J., Ji, J. D., Kim, T., Kim, K., Cho, C., Hwang, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311239111 · Cited by 114
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Li, Y., Porta‐Pardo, E., Tokheim, C. J., Bailey, M. H., Yaron, T. M., Stathias, V., Geffen, Y., Imbach, K. J., Cao, S., Anand, S. K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.014 · Cited by 124
Genome‐scale modeling of human metabolism – a systems biology approach
Mardinoğlu, A., Gatto, F., & Nielsen, J. (2013) · Biotechnology Journal · doi:10.1002/biot.201200275 · Cited by 115
Damiani, C., Colombo, R., Gaglio, D., Mastroianni, F., Pescini, D., Westerhoff, H. V., Mauri, G., Vanoni, M., & Alberghina, L. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005758 · Cited by 110
Current Controversies and Future Perspectives in Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., & Vestbo, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0405pp · Cited by 109
Divo, M. J., Celli, B. R., Poblador‐Plou, B., Calderón‐Larrañaga, A., de-Torres, J. P., Gimeno-Feliú, L. A., Bertó, J., Zulueta, J. J., Casanova, C., Pinto-Plata, V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193143 · Cited by 119
Haenig, C., Atias, N., Taylor, A. K., Mazza, A., Schaefer, M. H., Russ, J., Riechers, S., Jain, S., Coughlin, M., Fontaine, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108050 · Cited by 112
Role of oxidative stress in calcific aortic valve disease and its therapeutic implications
Greenberg, H. Z. E., Zhao, G., Shah, A. M., & Zhang, M. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab142 · Cited by 115
Moingeon, P. E., Kuenemann, M. A., & Guedj, M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.006 · Cited by 122
Prati, F., Cavalli, A., & Bolognesi, M. (2016) · Molecules · doi:10.3390/molecules21040466 · Cited by 110
Charting a Roadmap for Heart Failure Biomarker Studies
Ahmad, T., Fiuzat, M., Pencina, M. J., Geller, N. L., Zannad, F. M., Cleland, J. G. F., Snider, J., Blankenberg, S., Adams, K. F., Redberg, R. F., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.02.005 · Cited by 110
A global lipid map defines a network essential for Zika virus replication
Leier, H. C., Weinstein, J. B., Kyle, J. E., Lee, J., Bramer, L., Stratton, K. G., Kempthorne, D., Navratil, A. R., Tafesse, E. G., Hornemann, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17433-9 · Cited by 108
Topology of molecular interaction networks
Winterbach, W., Mieghem, P. V., Reinders, M. J. T., Wang, H., & de Ridder, D. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-90 · Cited by 109
Bell, I. R., & Koithan, M. S. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-191 · Cited by 109
Exploiting Protein-Protein Interaction Networks for Genome-Wide Disease-Gene Prioritization
Güney, E., & Oliva, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043557 · Cited by 109
Large-scale analysis of disease pathways in the human interactome
Agrawal, M., Žitnik, M., & Leskovec, J. (2017) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789813235533_0011 · Cited by 106
Computational drug repositioning based on multi-similarities bilinear matrix factorization
Yang, M., Wu, G., Zhao, Q., Li, Y., & Wang, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa267 · Cited by 109
Drug discovery for autism spectrum disorder: challenges and opportunities
Ghosh, A., Michalon, A., Lindemann, L., Fontoura, P., & Santarelli, L. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4102 · Cited by 108
A century after Fisher: time for a new paradigm in quantitative genetics
Nelson, R. M., Pettersson, M. E., & Carlborg, Ö. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.09.006 · Cited by 116
DiseaseConnect: a comprehensive web server for mechanism-based disease–disease connections
Liu, C.-C., Tseng, Y., Li, W., Wu, C.-Y., Mayzus, I., Rzhetsky, A., Sun, F., Waterman, M. S., Chen, J. J. W., Chaudhary, P. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku412 · Cited by 106
Self-citationFunction Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish
Kozol, R. A., Abrams, A. J., James, D. M., Buglo, E., Yan, Q., & Dallman, J. E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00055 · Cited by 116
CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling
Liu, J., Zhou, Y., Qi, X., Chen, J., Chen, W., Qiu, G., Wu, Z., & Wu, N. (2016) · Human Genetics · doi:10.1007/s00439-016-1739-6 · Cited by 110
Taroni, J., Greene, C. S., Martyanov, V., Wood, T. A., Christmann, R., Farber, H. W., Lafyatis, R., Denton, C. P., Hinchcliff, M., Pioli, P. A., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0417-1 · Cited by 110
Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach
Hu, Y.-S., Xin, J., Hu, Y. C., Zhang, L., & Wang, J. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0252-z · Cited by 117
Harnessing network pharmacology in drug discovery: an integrated approach
Joshi, C. P., Baldi, A., Kumar, N., & Pradhan, J. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03625-3 · Cited by 126
Systems biology and the integration of mechanistic explanation and mathematical explanation
Brigandt, I. (2013) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2013.06.002 · Cited by 109
Fagone, P., Ciurleo, R., Lombardo, S. D., Iacobello, C., Palermo, C. I., Shoenfeld, Y., Bendtzen, K., Bramanti, P., & Nicoletti, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102571 · Cited by 108
Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy
Deng, R., Shen, N., Yang, Y., Yu, H., Xu, S., Yang, Y.-W., Liu, S., Meguellati, K., & Yan, F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.013 · Cited by 106
Zaman, N., Li, L., Jaramillo, M. L., Sun, Z., Tibiche, C., Banville, M., Collins, C., Trifiro, M. A., Paliouras, M., Nantel, A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.028 · Cited by 111
Graphlet-based Characterization of Directed Networks
Sarajlić, A., Malod‐Dognin, N., Yaveroğlu, Ö. N., & Pržulj, N. (2016) · Scientific Reports · doi:10.1038/srep35098 · Cited by 106
Yang, J., Tian, S., Zhao, J., & Zhang, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105034 · Cited by 106
SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
Fiscon, G., Conte, F., Farina, L., & Paci, P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008686 · Cited by 108
Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
Hosp, F., Voßfeldt, H., Heinig, M., Vasiljević, D., Arumughan, A., Wyler, E., Landthaler, M., Hübner, N., Wanker, E. E., Lannfelt, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.030 · Cited by 106
Newman, M. E. J. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780198805090.003.0006 · Cited by 108
Integrative network analysis reveals molecular mechanisms of blood pressure regulation
Huan, T., Meng, Q., Saleh, M. A., Norlander, A. E., Joehanes, R., Zhu, J., Chen, B. H., Zhang, B., Johnson, A. D., Ying, S., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145399 · Cited by 102
Vella, D., Zoppis, I. F., Mauri, G., Mauri, P., & Silvestre, D. D. (2017) · EURASIP Journal on Bioinformatics and Systems Biology · doi:10.1186/s13637-017-0059-z · Cited by 105
A novel method to evaluate node importance in complex networks
Yang, Y., Lei, Y., Wang, X., Zhou, Z., Chen, Y., & Kou, T. (2019) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2019.121118 · Cited by 105
A Literature Review of Gene Function Prediction by Modeling Gene Ontology
Zhao, Y., Wang, J., Chen, J., Zhang, X., Guo, M., & Yu, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00400 · Cited by 105
Genetics of coronary artery disease in the post‐GWAS era
Chen, Z., & Schunkert, H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13362 · Cited by 111
Polypharmacology: The Rise of Multitarget Drugs over Combination Therapies
Rosini, M. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.25 · Cited by 103
Network representations of immune system complexity
Subramanian, N., Torabi‐Parizi, P., Gottschalk, R. A., Germain, R. N., & Dutta, B. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1288 · Cited by 104
Gene-environment interactions in asthma and allergic diseases: Challenges and perspectives
Kauffmann, F., & Démenais, F. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.038 · Cited by 105
Structural controllability of unidirectional bipartite networks
Nacher, J. C., & Akutsu, T. (2013) · Scientific Reports · doi:10.1038/srep01647 · Cited by 102
Belling, K., Russo, F., Jensen, A. B., Dalgaard, M., Westergaard, D., Meyts, E. R., Skakkebæk, N. E., Juul, A., & Brunak, S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx014 · Cited by 102
Addressing confounding artifacts in reconstruction of gene co-expression networks
Parsana, P., Ruberman, C., Jaffe, A. E., Schatz, M. C., Battle, A. J., & Leek, J. T. (2019) · Genome biology · doi:10.1186/s13059-019-1700-9 · Cited by 103
iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding
Chen, H., Cheng, F., & Li, J. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008040 · Cited by 104
Tourette, C., Li, B., Bell, R. N., O’Hare, S., Kaltenbach, L. S., Mooney, S. D., & Hughes, R. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523696 · Cited by 100
Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method
Cheng, F., Zhou, Y., Li, W., Liu, G., & Tang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041064 · Cited by 100
Tissue Specificity of Human Disease Module
Kitsak, M., Sharma, A., Menche, J., Güney, E., Ghiassian, S. D., Loscalzo, J., & Barabási, A.-Ĺ. (2016) · Scientific Reports · doi:10.1038/srep35241 · Cited by 99
Self-citationWicik, Z., Eyileten, C., Jakubik, D., Simões, S. N., Martins, D., Pavão, R., Siller-Matula, J. M., & Postula, M. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113743 · Cited by 100
Enhancing sepsis biomarker development: key considerations from public and private perspectives
Llitjos, J., Carrol, E. D., Osuchowski, M. F., Bonneville, M., Scicluna, B. P., Payen, D. M., Randolph, A. G., Witte, S., Rodríguez-Manzano, J., François, B., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05032-9 · Cited by 112
Piovesan, D., Giollo, M., Leonardi, E., Ferrari, C., & Tosatto, S. C. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv523 · Cited by 100
The pathobiology of perturbed mutant huntingtin protein–protein interactions in Huntington's disease
Wanker, E. E., Ast, A., Schindler, F., Trepte, P., & Schnoegl, S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14853 · Cited by 102
Network-assisted analysis to prioritize GWAS results: principles, methods and perspectives
Jia, P., & Zhao, Z. (2013) · Human Genetics · doi:10.1007/s00439-013-1377-1 · Cited by 99
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
Yi, S. S., Lin, S., Li, Y., Zhao, W., Mills, G. B., & Sahni, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.8 · Cited by 105
What does endotyping mean for treatment in chronic obstructive pulmonary disease?
Agustí, A. G. N., Celli, B. R., & Faner, R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32136-0 · Cited by 98
Karthikeyan, B. S., Ravichandran, J., Mohanraj, K., Vivek-Ananth, R. P., & Samal, A. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.07.225 · Cited by 97
Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases
Ritchie, S. C., Lambert, S. A., Arnold, M., Teo, S. M., Lim, S. I., Šćepanović, P., Marten, J., Zahid, S., Chaffin, M. D., Liu, Y., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00478-5 · Cited by 96
Evidence-Based Medicine Versus Personalized Medicine
de León, J. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182491383 · Cited by 98
Polypharmacology-based ceritinib repurposing using integrated functional proteomics
Kuenzi, B. M., Rix, L. L. R., Stewart, P. A., Fang, B., Kinose, F., Bryant, A. T., Boyle, T. A., Koomen, J. M., Haura, E. B., & Rix, U. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2489 · Cited by 99
The challenge of modeling protein assemblies: the CASP12‐CAPRI experiment
Lensink, M. F., Velankar, S. S., Baek, M., Heo, L., Seok, C., & Wodak, S. J. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25419 · Cited by 97
Zuo, J., Wang, X., Liu, Y., Ye, J., Liu, Q., Li, Y., & Li, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01472 · Cited by 98
The Emergence of Informative Higher Scales in Complex Networks
Klein, B., & Hoel, E. P. (2020) · Complexity · doi:10.1155/2020/8932526 · Cited by 98
Why is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality?
Pelkonen, O., Xu, Q., & Fan, T.-P. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.124323 · Cited by 109
Castro, M. A. A., Wang, X., Fletcher, M. N. C., Meyer, K. B., & Markowetz, F. M. (2012) · Genome biology · doi:10.1186/gb-2012-13-4-r29 · Cited by 98
Unifying aging and frailty through complex dynamical networks
Rutenberg, A. D., Mitnitski, A., Farrell, S. G., & Rockwood, K. J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.027 · Cited by 97
Kumar, N., Kumar, V., Anand, P., Kumar, V., Dwivedi, A. R., & Kumar, V. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116742 · Cited by 98
Social Simulation in the Social Sciences
Squazzoni, F., Jager, W., & Edmonds, B. (2013) · Social Science Computer Review · doi:10.1177/0894439313512975 · Cited by 111
Cellular and synaptic network defects in autism
Peça, J., & Feng, G. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.015 · Cited by 96
Exploring traditional chinese medicine by a novel therapeutic concept of network target
Li, S. (2016) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-016-2499-9 · Cited by 96
Menezes, L. F., Zhou, F., Patterson, A. D., Piontek, K. B., Krausz, K. W., Gonzalez, F. J., & Germino, G. G. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003053 · Cited by 98
Network Medicine in Pathobiology
Lee, L. Y.-H., & Loscalzo, J. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.03.009 · Cited by 95
Self-citationNetwork analysis reveals rare disease signatures across multiple levels of biological organization
Buphamalai, P., Kokotovic, T., Nagy, V., & Menche, J. (2021) · Nature Communications · doi:10.1038/s41467-021-26674-1 · Cited by 95
Single-cell and multivariate approaches in genetic perturbation screens
Liberali, P., Snijder, B., & Pelkmans, L. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3768 · Cited by 94
Batushansky, A., Toubiana, D., & Fait, A. (2016) · BioMed Research International · doi:10.1155/2016/8313272 · Cited by 105
Personalized medicine—a modern approach for the diagnosis and management of hypertension
Savoia, C., Volpe, M., Grassi, G., Borghi, C., Rosei, E. A., & Touyz, R. M. (2017) · Clinical Science · doi:10.1042/cs20160407 · Cited by 97
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 96
Network bioinformatics analysis provides insight into drug repurposing for COVID-19
Xu, L., Yu, J., Zhang, Z., Ren, J. F., Peluffo, A. E., Zhang, W., Zhao, Y., Wu, J., Yan, K., Cohen, D., et al. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100090 · Cited by 95
Neuroscience Needs Network Science
Barabási, D. L., Bianconi, G., Bullmore, E. T., Burgess, M., Chung, S., Eliassi‐Rad, T., George, D., Kovács, I. A., Makse, H. A., Nichols, T. E., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1014-23.2023 · Cited by 114
Self-citationSutherland, J. J., Webster, Y., Willy, J. A., Searfoss, G. H., Goldstein, K. M., Irizarry, A. R., Hall, D. G., & Stevens, J. L. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.17 · Cited by 95
Predicting disease associations via biological network analysis
Sun, K., Gonçalves, J. P., Larminie, C., & Pržulj, N. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-304 · Cited by 94
Intracranial Electrophysiology of the Human Default Network
Fox, K. C. R., Foster, B. L., Kucyi, A., Daitch, A. L., & Parvizi, J. (2018) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.02.002 · Cited by 96
Wang, T., Liu, X.-H., Guan, J. Z., Ge, S., Wu, M., Lin, J., & Yang, L.-R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.076 · Cited by 97
Bindu, N. V. M., Sankar, C. P., & Kumar, K. S. (2019) · Government Information Quarterly · doi:10.1016/j.giq.2019.02.005 · Cited by 94
Metadata
- Authors
- Barabási, A.-L., Gulbahce, N., & Loscalzo, J.
- Affiliations
- Northeastern University (US)
- Brigham and Women's Hospital (US)
- Venue
- Nature Reviews Genetics
- Published
- 2010-12-17
- Volume
- 12
- Issue
- 1
- Pages
- 56-68
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC3140052
- OpenAlex
- W2062533676
- Cited by
- 5,034
- References
- 140
- Citations by year
- 2026: 421 · 2025: 322 · 2024: 296 · 2023: 299 · 2022: 346 · 2021: 390 · 2020: 384 · 2019: 356 · 2018: 383 · 2017: 326 · 2016: 311 · 2015: 324 · 2014: 309 · 2013: 272 · 2012: 217
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL81587, HL 70819, U54HL070819, P01HL081587, R21HL089734, R01HL061795, HL-48743, P01HL048743, HL-061795, R37HL061795)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- network medicine, molecular networks, disease-associated genes, disease-associated mutations, therapeutic target, biomarkers, disease modules, complex diseases, genome-wide association study, full genome sequencing
- MeSH terms
- Disease, Humans, Gene Expression Profiling, Databases, Genetic, Gene Regulatory Networks, Metabolic Networks and Pathways, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
